Seroatlas · Human Serome Atlas

LHFPL5

LHFPL tetraspan subfamily member 5 protein

Also known as: DFNB67, dJ510O8.8, LHPL5_HUMAN, MGC33835, Tmhs

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8TAF8
Gene
LHFPL5
Ensembl
ENSG00000197753
Chromosome
6
Canonical length
219 aa
Protein class
Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters
Subcellular location
Vesicles

OverviewNCBI Gene

This gene is a member of the lipoma HMGIC fusion partner (LHFP) gene family, which is a subset of the superfamily of tetraspan transmembrane protein encoding genes. Mutations in this gene result in deafness in humans, and a mutation in a similar gene in mice results in deafness and vestibular dysfunction with severe degeneration of the organ of Corti. It is proposed to function in hair bundle morphogenesis. [provided by RefSeq, Jul 2008]

Canonical amino-acid sequenceUniProt

219 residues, UniProt reviewed canonical sequence.

>Q8TAF8|LHFPL5
     1  MVKLLPAQEA AKIYHTNYVR NSRAVGVMWG TLTICFSVLV MALFIQPYWI GDSVNTPQAG
    61  YFGLFSYCVG NVLSSELICK GGPLDFSSIP SRAFKTAMFF VALGMFLIIG SIICFSLFFI
   121  CNTATVYKIC AWMQLAAATG LMIGCLVYPD GWDSSEVRRM CGEQTGKYTL GHCTIRWAFM
   181  LAILSIGDAL ILSFLAFVLG YRQDKLLPDD YKADGTEEV

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against LHFPL5 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
4
Mean surface accessibility (rSASA)
0.31
Highest tissue expression
17 nTPM

Expression across tissuesHPA

Tissue

  • bone marrow: 17 nTPM
  • epididymis: 12 nTPM
  • pancreas: 11 nTPM
  • retina: 7.2 nTPM
  • skin: 6.7 nTPM
  • lung: 3.6 nTPM

Single-cell type

  • neutrophils: 92 nCPM
  • pancreatic acinar cells: 66 nCPM
  • epicardial cells: 59 nCPM
  • basal keratinocytes: 58 nCPM
  • suprabasal keratinocytes: 55 nCPM
  • esophageal suprabasal cells: 48 nCPM

Immune cell

  • neutrophil: 3.3 nTPM
  • basophil: 2.8 nTPM
  • naive B-cell: 0.8 nTPM
  • plasmacytoid DC: 0.7 nTPM
  • NK-cell: 0.6 nTPM
  • classical monocyte: 0.5 nTPM

Brain region

  • cerebral cortex: 39 nTPM
  • cerebellum: 37 nTPM
  • basal ganglia: 36 nTPM
  • hypothalamus: 34 nTPM
  • hippocampal formation: 33 nTPM
  • white matter: 33 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about LHFPL5.

Disease | AllUniProt

Conditions LHFPL5 is implicated in, by any mechanism.

Disease | GeneticClinVar

23 pathogenic / likely-pathogenic of 184 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
1.43
gnomAD pLI
0
gnomAD missense Z
0.3
DepMap mean gene effect
-0.09
DepMap dependency class
none

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of LHFPL5 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads LHFPL5 as an antibody target. Whether an autoantibody or antibody against LHFPL5 could matter depends on whether native LHFPL5 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

LHFPL5 is annotated at the cell surface, where native LHFPL5 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label LHFPL5 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/LHFPL5. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...